Skip to main content
If you continue browsing this website, you agree to our policies:
  • Terms and Conditions
  • Privacy & Cookies Policy
Continue
x
  • Home
  • Calendar
  • About
    About Open Classroom EUPATI Fellows Our Impact FAQ
  • Open Classroom
    Learning Catalogue Patient Expert Training Programme
  • Resources
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
  • EUPATI website
  • More
English ‎(en_wp)‎
Čeština ‎(cs)‎ Deutsch ‎(de_wp)‎ English ‎(en_wp)‎ Español ‎(es_wp)‎ Français ‎(fr_wp)‎ Italiano ‎(it_wp)‎ Nederlands ‎(nl_wp)‎ Português - Portugal ‎(pt)‎ Ελληνικά ‎(el_wp)‎
You are currently using guest access
Log in

    Side Drawer

    EUPATI Open Classroom
    Profile Calendar Home Calendar About Collapse Expand
    About Open Classroom EUPATI Fellows Our Impact FAQ
    Open Classroom Collapse Expand
    Learning Catalogue Patient Expert Training Programme
    Resources Collapse Expand
    Glossary EUPATI Toolbox Patient Engagement Roadmap Accessibility Resources Patient Education Compass
    EUPATI website

    Glossary

    Back

    Guarantee-time bias

    If a group of trial participants receiving a placebo are monitored/followed up from the moment they enrol in a trial, but the treatment for another group of trial participants does not begin straight away, this time lag can cause bias in the trial.  This particular type of bias is called 'guarantee-time bias'.

    Guarantee-time bias means that the participants in the treatment arm will only be monitored/followed up if they survive (or, for example, do not have symptoms that the treatment aims to prevent) for the whole of the time lag. Any that do not will be excluded from the trial, and this means the treatment arm is selected on a different basis to the placebo arm.

    The easiest way to avoid guarantee-time bias is to use matching. Participants in the treatment arm and the placebo arm are individually matched. If a participant in the treatment arm has to wait 30 days to begin the trial, they are matched with a placebo participant who has also survived or survived without symptoms for 30 days since enrolment. This is also known as establishing matched pairs.

    » Glossary

    Previous Activity
    Next Activity

    Footer

    You are currently using guest access (Log in)
    Policies
    Get the mobile app
    Powered by Moodle

    About EUPATI

    • About Open Classroom
    • FAQ
    • Contact us

    Start learning

    • Learning Catalogue
    • Patient Expert Training Programme

    Resources

    • EUPATI Toolbox
    • Patient Involvement Roadmap
    • Accessibility Resources

    Terms of Use & Privacy

    • Terms and Conditions
    • Privacy and Cookie Policy

    The EUPATI Open Classroom was initially launched with support from the EUPATI Reload project, funded by EIT Health. EIT Health is supported by EIT, a body of the European Union. 

    For more information about EUPATI, please access our website www.eupati.eu or contact us at openclassroom@eupati.eu

    EIT Health logo and EU logo

    © 2025 EUPATI

    • https://eupati.eu/
    • https://www.linkedin.com/company/15178871/admin/dashboard/
    • https://www.youtube.com/user/PatientsAcademy
    • https://www.instagram.com/eupatients/
    • https://www.facebook.com/eupati.eu/
    Select banner image